A carregar...
Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
BACKGROUND: Azelnidipine (AZL), a long-acting dihydropyridine-based calcium antagonist, has been recently approved and used for treating ischemic heart disease and cardiac remodeling after myocardial infarction, however, its effect on hyperglycemia-induced cardiac damage has not been studied. METHOD...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3004822/ https://ncbi.nlm.nih.gov/pubmed/21118576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-9-82 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|